3 recruiting, 2 completed, 2 unknown, 1 active not recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
| Not applicable | 1 | Active not recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Ascites, Malignant: new trials by email Literature Review of Ascites, Malignant trials Research Report on Ascites, Malignant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-PD-1 in Combination With Systemic Chemotherapy With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites Gastric Cancer Peritoneal Metastases, Gastric Cancer (GC) | Recruiting | Zhejiang Cancer Hospital | 50 | 2026-07-01 | 2026-10-02 | |
| Retlirafusp Alfa Plus SOX and Intraperitoneal Nab-Paclitaxel for Advanced Gastric/GEJ Cancer With Malignant Ascites Retlirafusp Alfa + SOX + Intraperitoneal Nab-Paclitaxel - Gastric Cancer (GC), Peritoneal Metastases From Gastric Cancer | Not applicable | Active not recruiting | Zhejiang Cancer Hospital | 5 | 2026-06-01 | 2026-10-02 |
| Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites zoledronic acid plus Sintilimab intraperitoneal injection - Cancer of Stomach, Adenocarcinoma, Ascites, Malignant | Phase 1 / Phase 2 | Recruiting | Qilu Hospital of Shandong University | 24 | 2024-09-12 | 2025-11-19 |
| PMCF Study of the CE-marked Drainova® ArgentiC Catheter Indwelling catheter - Pleural Effusion, Pleural Effusion, Malignant | Completed | ewimed GmbH | 169 | 2024-06-26 | 2026-03-12 | |
| QOL and Sarcopenia in Patients With Ascites Quality of Life surveys - Ascites Hepatic, Ascites, Malignant | Recruiting | Abramson Cancer Center at Penn Medicine | 70 | 2023-05-23 | 2026-06-15 | |
| Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites Sintilimab in Combination With S-1/oxaliplatin With nab-paclitaxel intraperitoneal infusion, Blood samples, tumor biopsy specimens, ascites, and feces samples will be collected - Gastric Cancer, Peritoneal Metastases | Phase 2 | Unknown | Zhejiang Cancer Hospital | 35 | 2023-03-01 | 2023-09-21 |
| Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) Pleural Effusion, Malignant, Ascites, Malignant | Completed | Travera Inc | 72 | 2022-07-15 | 2026-04-13 | |
| Quality of Life of Patients Who Have Rocket Indwelling Pleural Catheter Drainage or Repeated Large Volume Paracentesis Large Volume Paracentesis, Rocket Indwelling Pleural Catheter - Ascites, Malignant | Unknown | Gloucestershire Hospitals NHS Foundation Trust | 20 | 2018-09-01 | 2018-06-11 |
Ascites (8) · Stomach Neoplasms (5) · Pleural Effusion, Malignant (2) · Adenocarcinoma (1) · Anus Neoplasms (1) · Appendiceal Neoplasms (1) · Breast Neoplasms (1) · Carcinoma (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Neuroendocrine (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Pancreatic Ductal (1) · Carcinoma, Renal Cell (1) · Carcinoma, Small Cell (1) · Cholangiocarcinoma (1)
Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Neoplasms (6) · Neoplasms by Site (6) · Digestive System Diseases (5) · Digestive System Neoplasms (5) · Gastrointestinal Diseases (5) · Gastrointestinal Neoplasms (5) · Stomach Diseases (5) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Pleural Diseases (2) · Pleural Neoplasms (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2)
Blood Specimen Collection (1) · Catheters, Indwelling (1) · Zoledronic Acid (1) · sintilimab (1)
Zhejiang Cancer Hospital (3) · Abramson Cancer Center at Penn Medicine (1) · Gloucestershire Hospitals NHS Foundation Trust (1) · Qilu Hospital of Shandong University (1) · Travera Inc (1) · ewimed GmbH (1)
China (4) · United States (2) · Germany (1)
Jieer Ying, Dr (2) · Heidrun Steinle, Dr (1) · Mark Stevens, Phd (1) · Michael Soulen, MD (1) · Rob Kimmerling, Phd (1)